Dupixent 300 MG/2 ML syringe 2ML
Ended Awarded
- Contract number
- SPE2DB25FJTS3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,379
Award facts
- Contract value 100% obligated
- $10,379.06 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $10,379.06 delivery order to AmerisourceBergen Drug Corp for 300 mg/2 mL Dupixent syringes on September 26, 2025, with an ultimate completion date of September 29, 2025. This firm fixed-price, non-set-aside delivery order will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a biologic medication used to treat moderate-to-severe atopic dermatitis, asthma, and other allergic conditions, representing a critical pharmaceutical supply requirement for Department of Defense medical operations.
This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. The prime IDV serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The contract reflects the company's established capability to meet federal procurement requirements through open competition, with a portfolio spanning specialty medications, brand-name and generic drugs, vaccines, and specialized medical supplies across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FJTS3?
SPE2DB25FJTS3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 26, 2025.
How much is contract SPE2DB25FJTS3 worth?
The government has obligated $10,379 on SPE2DB25FJTS3.
Is contract SPE2DB25FJTS3 an order under another contract?
Yes. SPE2DB25FJTS3 is a delivery order under SPE2DB22D2005, an indefinite delivery contract.
Was contract SPE2DB25FJTS3 competed?
The extent of competition for SPE2DB25FJTS3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award